Trade Summary

2 days ago, EVNIN LUKE, serving as Dir at Werewolf Therapeutics, Inc. (HOWL), sold 76,928 shares at $0.37 per share, for a total transaction value of $28,463.36. Following this transaction, EVNIN LUKE now holds 300,283 shares of HOWL.

This sale represents a 20.39% decrease in EVNIN LUKE's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 10, 2026 at 5:20 PM ET, 1 day after the trade was made.

Werewolf Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.